Caxton Associates LP Agenus Inc Transaction History

Caxton Associates LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.12 - $1.88 $311,206 - $522,382	277,863 Added 247.27%	390,234 $440,000
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $147,206 - $229,236	112,371 New	112,371 $179,000
Q3 2020 Nov 16, 2020	SELL	$2.98 - $5.2 $96,316 - $168,069	-32,321 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.29 - $4.24 $74,015 - $137,041	32,321 New	32,321 $127,000
Q1 2020 May 15, 2020	SELL	$1.92 - $4.39 $138,606 - $316,918	-72,191 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.41 - $4.4 $173,980 - $317,640	72,191 New	72,191 $294,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.